{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:54:38Z","timestamp":1783385678534,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sickle cell disease (SCD) is an inherited hemoglobinopathy disorder associated with chronic hemolysis. A major complication is vaso-occlusive crisis (VOC), associating frequent hospitalization, morbidity and mortality. The aim of this study was to investigate whether hemolysis biomarkers were able to predict VOC risk in adult patients with SCD requiring hospitalization within 1 year. This single-center prospective study included adult patients with SCD at steady state or during VOC. A total of 182 patients with SCD were included, 151 at steady state and 31 during VOC. Among the 151 patients at steady state 41 experienced VOC within 1 year (median: 3.0\u00a0months [2.0\u20136.5]). We observed an increase of lactate dehydrogenase (LDH) (<jats:italic>p<\/jats:italic>\u2009=\u20090.01) and hemolysis index (HI) (<jats:italic>p<\/jats:italic>\u2009=\u20090.0043) during VOC compared to steady state. Regarding patients with VOC requiring hospitalization, LDH (<jats:italic>p<\/jats:italic>\u2009=\u20090.0073) and HI (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) were increased. In unadjusted logistic regression, LDH\u2009&gt;\u2009median (&gt;\u2009260 U\/L) (RR\u2009=\u20093.6 [1.29\u201310.88], <jats:italic>p<\/jats:italic>\u2009=\u20090.0098) and HI\u2009&gt;\u2009median (&gt;\u20098 UA\/L) (RR\u2009=\u20093.13 [1.91\u20135.33]; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) were associated with VOC. The association of LDH\u2009&gt;\u2009260 U\/L and HI\u2009&gt;\u200912 UA\/L presented a sensitivity of 90%, and a specificity of 72.9% to predict VOC. The association of LDH and HI cut-off was able to predict VOC risk in SCD.<\/jats:p>","DOI":"10.1038\/s41598-023-48324-w","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:02:25Z","timestamp":1701432145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Lactate dehydrogenase and hemolysis index to predict vaso-occlusive crisis in sickle cell disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Guillaume","family":"Feugray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Dumesnil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilien","family":"Grall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ygal","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Girot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Fettig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Billoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"48324_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cca.2019.02.026","volume":"493","author":"SLDO Toledo","year":"2019","unstructured":"Toledo, S. L. D. O., Guedes, J. V. M., Alpoim, P. N., Rios, D. R. A. & Pinheiro, M. D. B. Sickle cell disease: Hemostatic and inflammatory changes, and their interrelation. Clin. Chim. Acta 493, 129\u2013137 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"48324_CR2","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel, F. B., Steinberg, M. H. & Rees, D. C. Sickle cell disease. N. Engl. J. Med. 376, 1561\u20131573 (2017).","journal-title":"N. Engl. J. Med."},{"key":"48324_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2016.04.035","volume":"458","author":"K Stankovic Stojanovic","year":"2016","unstructured":"Stankovic Stojanovic, K. & Lionnet, F. Lactate dehydrogenase in sickle cell disease. Clin. Chim. Acta 458, 99\u2013102 (2016).","journal-title":"Clin. Chim. Acta"},{"key":"48324_CR4","doi-asserted-by":"publisher","first-page":"e2095","DOI":"10.1371\/journal.pone.0002095","volume":"3","author":"JG Taylor","year":"2008","unstructured":"Taylor, J. G. et al. Chronic hyper-hemolysis in sickle cell anemia: Association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS ONE 3, e2095 (2008).","journal-title":"PLoS ONE"},{"key":"48324_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/jalm\/jfz006","volume":"5","author":"MA Barbhuiya","year":"2020","unstructured":"Barbhuiya, M. A. et al. Automated measurement of plasma cell-free hemoglobin using the hemolysis index check function. J. Appl. Lab. Med. 5, 281\u2013289 (2020).","journal-title":"J. Appl. Lab. Med."},{"key":"48324_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1515\/CCLM.2009.218","volume":"47","author":"G Lippi","year":"2009","unstructured":"Lippi, G. et al. Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Clin. Chem. Lab. Med. 47, 934\u2013939 (2009).","journal-title":"Clin. Chem. Lab. Med."},{"key":"48324_CR7","doi-asserted-by":"publisher","first-page":"883812","DOI":"10.3389\/fcvm.2022.883812","volume":"9","author":"G Feugray","year":"2022","unstructured":"Feugray, G. et al. Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease. Front. Cardiovasc. Med. 9, 883812 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"48324_CR8","doi-asserted-by":"publisher","first-page":"858911","DOI":"10.3389\/fmed.2022.858911","volume":"9","author":"G Feugray","year":"2022","unstructured":"Feugray, G. et al. Assessment of reticulocyte and erythrocyte parameters from automated blood counts in vaso-occlusive crisis on sickle cell disease. Front. Med. 9, 858911 (2022).","journal-title":"Front. Med."},{"key":"48324_CR9","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees, D. C., Williams, T. N. & Gladwin, M. T. Sickle-cell disease. Lancet 376, 2018\u20132031 (2010).","journal-title":"Lancet"},{"key":"48324_CR10","doi-asserted-by":"publisher","first-page":"117223","DOI":"10.1016\/j.cca.2023.117223","volume":"540","author":"F Njoku","year":"2023","unstructured":"Njoku, F. et al. Associations of hemolysis and anemia with cardiopulmonary dysfunction in an adult sickle cell disease cohort. Clin. Chim. Acta 540, 117223 (2023).","journal-title":"Clin. Chim. Acta"},{"key":"48324_CR11","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1182\/blood.V96.9.3276","volume":"96","author":"LA Styles","year":"2000","unstructured":"Styles, L. A., Aarsman, A. J., Vichinsky, E. P. & Kuypers, F. A. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood 96, 3276\u20133278 (2000).","journal-title":"Blood"},{"key":"48324_CR12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.hoc.2022.06.005","volume":"36","author":"E Saah","year":"2022","unstructured":"Saah, E., Fadaei, P., Gurkan, U. A. & Sheehan, V. Sickle cell disease pathophysiology and related molecular and biophysical biomarkers. Hematol. Oncol. Clin. North Am. 36, 1077\u20131095 (2022).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"48324_CR13","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2015-04-641522","volume":"125","author":"G Mecabo","year":"2015","unstructured":"Mecabo, G., Yamamoto, M., Biassi, T. P. & Figueiredo, M. S. Lactate dehydrogenase isoenzyme 3 and hemolysis in sickle cell anemia: A possible correlation?. Blood 125, 3821\u20133822 (2015).","journal-title":"Blood"},{"key":"48324_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1537-2995.2006.00679.x","volume":"46","author":"SK Ballas","year":"2006","unstructured":"Ballas, S. K. & Marcolina, M. J. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 46, 105\u2013110 (2006).","journal-title":"Transfusion"},{"key":"48324_CR15","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.clinbiochem.2012.07.114","volume":"45","author":"K Stankovic Stojanovic","year":"2012","unstructured":"Stankovic Stojanovic, K. et al. High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients. Clin. Biochem. 45, 1578\u20131582 (2012).","journal-title":"Clin. Biochem."},{"key":"48324_CR16","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1038\/s41598-020-59258-y","volume":"10","author":"S Alkindi","year":"2020","unstructured":"Alkindi, S. et al. Predictors of impending acute chest syndrome in patients with sickle cell anaemia. Sci. Rep. 10, 2470 (2020).","journal-title":"Sci. Rep."},{"key":"48324_CR17","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bjh.13339","volume":"169","author":"JB Vidler","year":"2015","unstructured":"Vidler, J. B., Gardner, K., Amenyah, K., Mijovic, A. & Thein, S. L. Delayed haemolytic transfusion reaction in adults with sickle cell disease: A 5-year experience. Br. J. Haematol. 169, 746\u2013753 (2015).","journal-title":"Br. J. Haematol."},{"key":"48324_CR18","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","volume":"107","author":"GJ Kato","year":"2006","unstructured":"Kato, G. J. et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107, 2279\u20132285 (2006).","journal-title":"Blood"},{"key":"48324_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1182\/blood-2012-10-462135","volume":"121","author":"SK Ballas","year":"2013","unstructured":"Ballas, S. K. Lactate dehydrogenase and hemolysis in sickle cell disease. Blood 121, 243\u2013244 (2013).","journal-title":"Blood"},{"key":"48324_CR20","first-page":"433","volume":"16","author":"G Lippi","year":"2018","unstructured":"Lippi, G., Favaloro, E. J. & Franchini, M. Haemolysis index for the screening of intravascular haemolysis: A novel diagnostic opportunity?. Blood Transfus. 16, 433\u2013437 (2018).","journal-title":"Blood Transfus."},{"key":"48324_CR21","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0114","author":"C Gils","year":"2023","unstructured":"Gils, C., Hansen, D. L., Nybo, M. & Frederiksen, H. Elevated hemolysis Index is associated with higher risk of cardiovascular diseases. Clin. Chem. Lab. Med. https:\/\/doi.org\/10.1515\/cclm-2023-0114 (2023).","journal-title":"Clin. Chem. Lab. Med."},{"key":"48324_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clinbiochem.2021.11.010","volume":"100","author":"C B\u00fcrki","year":"2022","unstructured":"B\u00fcrki, C., Volleberg, M., Brunner, D., Schmugge, M. & Hersberger, M. Using the hemolysis index of Abbott\u2019s Alinity c for the measurement of plasma free hemoglobin in ECMO patients. Clin. Biochem. 100, 67\u201370 (2022).","journal-title":"Clin. Biochem."},{"key":"48324_CR23","doi-asserted-by":"publisher","first-page":"e0124034","DOI":"10.1371\/journal.pone.0124034","volume":"10","author":"HR Omar","year":"2015","unstructured":"Omar, H. R. et al. Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support. PLoS ONE 10, e0124034 (2015).","journal-title":"PLoS ONE"},{"key":"48324_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ebiom.2016.06.038","volume":"10","author":"P Bartolucci","year":"2016","unstructured":"Bartolucci, P. et al. Score predicting acute chest syndrome during vaso-occlusive crises in adult sickle-cell disease patients. EBioMedicine 10, 305\u2013311 (2016).","journal-title":"EBioMedicine"},{"key":"48324_CR25","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/jcm11030630","volume":"11","author":"T Gentinetta","year":"2022","unstructured":"Gentinetta, T. et al. Plasma-derived hemopexin as a candidate therapeutic agent for acute vaso-occlusion in sickle cell disease: Preclinical evidence. J. Clin. Med. 11, 630 (2022).","journal-title":"J. Clin. Med."},{"key":"48324_CR26","first-page":"124","volume":"16","author":"EC Cardoso","year":"2023","unstructured":"Cardoso, E. C. et al. Changes in heme levels during acute vaso-occlusive crisis in sickle cell anemia. Hematol. Oncol. Stem Cell Ther. 16, 124\u2013132 (2023).","journal-title":"Hematol. Oncol. Stem Cell Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48324-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48324-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48324-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:12:45Z","timestamp":1701432765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-48324-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["48324"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-48324-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21198"}}